Osteocalcin and C-terminal telopeptide of type I collagen in serum and saliva: A cross-sectional pilot study on correlations and implications for MRONJ risk stratification in women on antiresorptive medications.
Researchers measured bone-turnover markers in blood and saliva from women on antiresorptive medications to evaluate their potential for identifying those at risk of medication-related jaw osteonecrosis. Serum osteocalcin showed promise as a biomarker for risk stratification, though findings require validation in larger studies before clinical use.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceRelated CPD from Vital Pulp
Managing the Pregnant Dental Patient
Confident, evidence-based dental care from the first trimester to the postpartum period
The Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall